DE69429536T2 - Analgetisches Mittel und dessen Verwendung - Google Patents

Analgetisches Mittel und dessen Verwendung

Info

Publication number
DE69429536T2
DE69429536T2 DE69429536T DE69429536T DE69429536T2 DE 69429536 T2 DE69429536 T2 DE 69429536T2 DE 69429536 T DE69429536 T DE 69429536T DE 69429536 T DE69429536 T DE 69429536T DE 69429536 T2 DE69429536 T2 DE 69429536T2
Authority
DE
Germany
Prior art keywords
analgesic agent
analgesic
agent
levobupivacaine
anaesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69429536T
Other languages
English (en)
Other versions
DE69429536D1 (de
Inventor
Hazel Bardsley
Robert William Gristwood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69429536(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321061A external-priority patent/GB9321061D0/en
Priority claimed from GB9408014A external-priority patent/GB9408014D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of DE69429536D1 publication Critical patent/DE69429536D1/de
Publication of DE69429536T2 publication Critical patent/DE69429536T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69429536T 1993-10-13 1994-10-13 Analgetisches Mittel und dessen Verwendung Expired - Lifetime DE69429536T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321061A GB9321061D0 (en) 1993-10-13 1993-10-13 Analgestic agent and its use
GB9408014A GB9408014D0 (en) 1994-04-22 1994-04-22 Analgesic agent and its use

Publications (2)

Publication Number Publication Date
DE69429536D1 DE69429536D1 (de) 2002-01-31
DE69429536T2 true DE69429536T2 (de) 2002-06-20

Family

ID=26303667

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69429536T Expired - Lifetime DE69429536T2 (de) 1993-10-13 1994-10-13 Analgetisches Mittel und dessen Verwendung
DE69402330T Expired - Lifetime DE69402330T2 (de) 1993-10-13 1994-10-13 Analgetisches mittel und dessen verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69402330T Expired - Lifetime DE69402330T2 (de) 1993-10-13 1994-10-13 Analgetisches mittel und dessen verwendung

Country Status (15)

Country Link
US (1) US5708011A (de)
EP (2) EP0727210B1 (de)
JP (2) JPH09503778A (de)
KR (1) KR100365979B1 (de)
CN (1) CN1074920C (de)
AT (2) ATE210982T1 (de)
AU (1) AU694453B2 (de)
DE (2) DE69429536T2 (de)
DK (2) DK0727210T3 (de)
ES (2) ES2170179T3 (de)
GR (1) GR3023289T3 (de)
HK (1) HK1006420A1 (de)
NO (1) NO308508B1 (de)
PT (1) PT727210E (de)
WO (1) WO1995010277A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9507677D0 (en) * 1995-04-13 1995-05-31 Chiroscience Ltd Pharmaceutical formulation and dose
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE69628743T2 (de) * 1995-04-13 2004-05-13 Darwin Discovery Ltd., Slough Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
GB9704351D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704370D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
EP0998287B1 (de) * 1997-07-22 2003-05-07 Darwin Discovery Limited Verwendung von levobupivacain
ATE535232T1 (de) 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
CA2309548A1 (en) * 1997-11-14 1999-05-27 Skyepharma Inc. Production of multivesicular liposomes
EP1032390B1 (de) * 1997-11-19 2003-11-12 Darwin Discovery Limited Anästhetikum
US6277413B1 (en) 1998-07-17 2001-08-21 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
IL158819A0 (en) * 2001-05-31 2004-05-12 Skyepharma Inc Encapsulation of nanosuspensions in liposomes and microspheres
ATE502621T1 (de) * 2001-11-14 2011-04-15 Durect Corp Katheterinjizierbare depotzusammensetzungen und deren verwendung
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
NZ533435A (en) * 2001-11-14 2007-10-26 Alza Corp Injectable depot compositions and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
KR20050083605A (ko) * 2002-07-31 2005-08-26 알자 코포레이션 주사 가능한 다원성 중합체 데포트 조성물 및 이의 용도
MXPA05001242A (es) * 2002-07-31 2005-06-08 Alza Corp Composiciones de deposito inyectable y usos de las mismas.
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
CN102307895A (zh) * 2008-12-04 2012-01-04 里兰斯坦福初级大学理事会 用于治疗或预防麻醉药停药症状的方法和组合物
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CN106214670B (zh) * 2016-07-25 2020-12-29 上海璃道医药科技有限公司 酰胺类药物的用途
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
DE69628743T2 (de) * 1995-04-13 2004-05-13 Darwin Discovery Ltd., Slough Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen

Also Published As

Publication number Publication date
KR100365979B1 (ko) 2003-07-22
EP0727210A2 (de) 1996-08-21
CN1133010A (zh) 1996-10-09
JPH09503778A (ja) 1997-04-15
NO961479L (no) 1996-06-11
AU7859494A (en) 1995-05-04
ATE210982T1 (de) 2002-01-15
ATE150643T1 (de) 1997-04-15
ES2101578T3 (es) 1997-07-01
AU694453B2 (en) 1998-07-23
NO308508B1 (no) 2000-09-25
NO961479D0 (no) 1996-04-12
GR3023289T3 (en) 1997-07-30
PT727210E (pt) 2002-06-28
DK0727210T3 (da) 2002-04-15
DE69402330D1 (de) 1997-04-30
EP0723445B1 (de) 1997-03-26
CN1074920C (zh) 2001-11-21
DK0723445T3 (da) 1997-10-06
ES2170179T3 (es) 2002-08-01
DE69402330T2 (de) 1997-07-03
EP0727210B1 (de) 2001-12-19
HK1006420A1 (en) 1999-02-26
DE69429536D1 (de) 2002-01-31
JP2006213736A (ja) 2006-08-17
EP0727210A3 (de) 1998-03-04
EP0723445A1 (de) 1996-07-31
US5708011A (en) 1998-01-13
WO1995010277A1 (en) 1995-04-20

Similar Documents

Publication Publication Date Title
DE69429536T2 (de) Analgetisches Mittel und dessen Verwendung
DE782855T1 (de) Antiinflammatorische wirkstoffe zur aüsserlichen anwendung
DE69204639T2 (de) Verwendung von Modafinil zur Herstellung eines antiischämischen Arzneimittels.
DE69416332T2 (de) Einführungsstilett für medizinsche kanüle und kanüle
BR9403783A (pt) Uso de uma composição cosmética
FR2715845B1 (fr) Composition cosmétique et/ou dermatologique contenant du vinaigre.
ATE243196T1 (de) Piperidine und pyrrolidine
DE69524871T2 (de) Benzopyrans und deren verwendung als therapeutische mittel
GB9704351D0 (en) Levobupivacaine and its use
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
DK0981347T3 (da) Anvendelsen af levobupivacain i ansigtkirurgi
DE69628743D1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
DE69528261T2 (de) Benzopyrane und deren verwendung als therapeutische mittel
ATE114464T1 (de) Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
DE69314952T2 (de) 4-acylamino-benzamide und deren verwendung als fungizide
DE9306458U1 (de) Modellsatz zur Demonstration von Wasserstoffbrücken und Assoziationen
ITFI920241A0 (it) Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro
NL1001075A1 (nl) Therapeutisch tractietoestel en sluitband daarvoor.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition